.png){kind=icon}
.png){kind=icon}
Return
Co-administration of the iRGD tumor-penetrating peptide improves the tumor immunostimulatory effects of low-dose IL-2
.png){kind=icon}
OA
AI
DOI：10.1158/1538-7445.SABCS18-1106.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Journal
IF:
16.6
Papers:
10.9W
Citations:
11.9W